This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange lost 3.68 points to 608.26 Monday. Three capital pool shells announced their qualifying transaction plans this morning. Refreshingly, none of the QTs is a marijuana deal. First, there is Doron Cohen's first capital pool shell, A-Labs Capital I Inc. (ALBS: halted), which plans to acquire an Israeli medical device company called Hisense Ltd. This target is not to be confused with the Chinese television manufacturer called Hisense Co. Ltd.

Israel's Hisense was founded in 1991 by Haim Shtalryd and three other engineers. In 1992, the company began selling its Babysense baby-breathing monitor. Babysense is placed under a baby's mattress. It is meant to prevent sudden infant death syndrome (SIDS) by alerting parents if their baby stops breathing. According to Hisense, about 22,000 babies die from SIDS each year. SIDS affects seemingly healthy babies, who appear to have just stopped breathing in their sleep. Its cause is unknown.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS